Offer An Article

Pandemic Latest News

pharma

Indemnity offered to Moderna, with conditions

Drugmaker Moderna is said to have secured an offer of legal indemnity regarding its COVID-19 vaccine from the Government, albeit with certain provisions. Individuals familiar with the matter said an offer has been sent to the drugmaker, which is based in the United States, reports The Economic Times. The company’s board of directors are expected …

Indemnity offered to Moderna, with conditions Read More »

Pfizer vaccine on the cusp of securing Indian approval, CEO says

The Pfizer vaccine against COVID-19 is on the verge of securing approval for use in India. This is according to the drugmaker’s chief executive officer Albert Bourla who, speaking at a virtual event, said they were in the “final stages” of receiving the nod and said “I hope very soon we will finalise an agreement …

Pfizer vaccine on the cusp of securing Indian approval, CEO says Read More »

Indian pharma to get US$1.3 billion boon

Against the backdrop of the COVID-19 pandemic in India, a US$1.3 billion fund will be established to bolster Indian pharma and promote domestic manufacturing to reduce import dependency.  The report, published in BloombergQuint, identifies “supply chain disruptions due to the coronavirus pandemic” as the rationale behind the decision, noting that Indian pharma’s reliance on China …

Indian pharma to get US$1.3 billion boon Read More »

APIs: No shortages yet, but pharma still has misgivings

The Union Government has sought to quell concerns over an imminent shortage of active pharmaceutical ingredients (APIs) and medicines in the country due to the novel coronavirus (COVID-19) outbreak. However, individuals from the pharmaceutical sector are still disconcerted.  The outbreak has had a kn0ck-on effect on multiple industries in India. As well as pharma, chemicals, …

APIs: No shortages yet, but pharma still has misgivings Read More »

Paracetamol prices spike amidst COVID-19 outbreak

The COVID-19 outbreak that originated China and has since mushroomed to several countries worldwide – including India – has had a knock-on effect on multiple industries including the pharmaceutical industry. This ripple effect has manifested in a spike in paracetamol prices.  At the time of writing, COVID-19 has infected in excess of 73,000 and resulted …

Paracetamol prices spike amidst COVID-19 outbreak Read More »

Essential medicines export ban on the cards?

The Government of India is contemplating imposing a ban on the exports of twelve essential medicines amidst the outbreak of the novel coronavirus (COVID-19) which has infected tens of thousands of people worldwide.  The twelve essential medicines that could be affected include antibiotics, hormone drugs, and vitamins. A report is planned to be submitted to …

Essential medicines export ban on the cards? Read More »

‘In a digital world’ – Experts call for digital pharma

Multiple stakeholders from the Indian pharmaceutical and healthcare industries are calling for increased digitisation, arguing that a trend towards ‘digital pharma’ is fuelling the sector’s growth. “To understand how the digital transformation is occurring in pharma marketing, we would need to look at both the patient’s side and the healthcare professional’s side,” asserted Atul Sharma, …

‘In a digital world’ – Experts call for digital pharma Read More »

FDA India: A single regulator on the cards?

A single regulator for food, medical devices, and medicines is on the cards in India, as the government think tank Niti Aayog has proposed a body analogous to the Food and Drugs Administration (FDA) in the United States.  At present, food safety is overseen by the Food Safety and Standards Authority of India (FSSAI) and …

FDA India: A single regulator on the cards? Read More »

Cyberattacks: A crisis in Indian pharma?

The pharmaceutical sector in India is the sixth most-affected industry of its kind in the world in terms of cyberattacks.  Attempted malicious attacks hit almost 45 percent of the sector’s devices in India last year, an increase from 44 percent the year before. Only the pharmaceutical industries in Pakistan, Egypt, Mexico, Indonesia, and Spain were …

Cyberattacks: A crisis in Indian pharma? Read More »

China reforms laws on generic medicines

Relaxed drug legislation in China comes as a boon for patients, who will now be able to use generic medicines made in other countries such as India.  Generic medicines unapproved in China were hitherto classified as counterfeit drugs, making their use illegal. Now, however, a session of the national legislature has relaxed this stipulation. Patients …

China reforms laws on generic medicines Read More »